The first in the country! Kelun Pharmaceutical's Cyramza Biosimilar Receives Clinical Approval-News-Tianya Pharmaceutical Network


2022-09-22: [Chinese Article Link] Today, the Sichuan Collon Pharmaceuticals Industry issued an announcement stating that the reconstitution of the antivascular intra-growth factor receptor 2 (VEGFR 2) developed by its controlling subsidiary, Sichuan Colombote Biopharmaceuticals Co. Ltd., had been approved by the National Directorate-General


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.




Trending in China

What China Reads


The first in the country! Kelun Pharmaceutical's Cyramza Biosimilar Receives Clinical Approval-News-Tianya Pharmaceutical Network


2022-09-22: [Article Link] Today, the Sichuan Collon Pharmaceuticals Industry issued an announcement stating that the reconstitution of the antivascular intra-growth factor receptor 2 (VEGFR 2) developed by its controlling subsidiary, Sichuan Colombote Biopharmaceuticals Co. Ltd., had been approved by the National Directorate-General

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.